You must log in to view this page.

Oramed Pharmaceuticals Inc.

NASDAQ: ORMP
Share price (12/26/24): $2.36
Market cap (12/26/24): $95.1 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.3

from 8-K 5 pages Second Amendment to Stock Purchase Agreement

12/34/56

EX-2.2

from 10-Q 2 pages First Amendment to Stock Purchase Agreement

12/34/56

EX-2.1

from 8-K 42 pages Stock Purchase Agreement Between Oramed Pharmaceuticals Inc. and Sorrento Therapeutics, Inc. August 7, 2023 Stock Purchase Agreement

12/34/56

EX-2.1

from 8-K 4 pages Plan of Conversion of Oramed Pharmaceuticals Inc., a Nevada Corporation to Oramed Pharmaceuticals Inc., a Delaware Corporation

12/34/56

EX-2.2

from 8-K/A ~10 pages Plan of reorganization, merger, acquisition or similar

12/34/56

Oramed Pharmaceuticals Inc. Watch

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

Oramed Pharmaceuticals Inc.